Growth Metrics

Noble Romans (NROM) EBITDA Margin (2016 - 2025)

Noble Romans has reported EBITDA Margin over the past 15 years, most recently at 19.77% for Q3 2025.

  • Quarterly results put EBITDA Margin at 19.77% for Q3 2025, up 903.0% from a year ago — trailing twelve months through Sep 2025 was 14.68% (up 46.0% YoY), and the annual figure for FY2024 was 9.74%, down 1419.0%.
  • EBITDA Margin for Q3 2025 was 19.77% at Noble Romans, down from 22.4% in the prior quarter.
  • Over the last five years, EBITDA Margin for NROM hit a ceiling of 35405.24% in Q1 2021 and a floor of 11.87% in Q4 2022.
  • Median EBITDA Margin over the past 5 years was 13.74% (2023), compared with a mean of 2902.27%.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 3538358bps in 2021 and later crashed -3540065bps in 2022.
  • Noble Romans' EBITDA Margin stood at 2.95% in 2021, then crashed by -302bps to 11.87% in 2022, then surged by 276bps to 20.87% in 2023, then tumbled by -91bps to 1.85% in 2024, then soared by 971bps to 19.77% in 2025.
  • The last three reported values for EBITDA Margin were 19.77% (Q3 2025), 22.4% (Q2 2025), and 13.34% (Q1 2025) per Business Quant data.